418 related articles for article (PubMed ID: 25899337)
1. Designing and exploring active N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients.
Palace-Berl F; Pasqualoto KF; Jorge SD; Zingales B; Zorzi RR; Silva MN; Ferreira AK; de Azevedo RA; Teixeira SF; Tavares LC
Eur J Med Chem; 2015; 96():330-9. PubMed ID: 25899337
[TBL] [Abstract][Full Text] [Related]
2. Investigating the structure-activity relationships of N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds.
Palace-Berl F; Pasqualoto KFM; Zingales B; Moraes CB; Bury M; Franco CH; da Silva Neto AL; Murayama JS; Nunes SL; Silva MN; Tavares LC
Eur J Med Chem; 2018 Jan; 144():29-40. PubMed ID: 29247858
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, leishmanicidal, trypanocidal and cytotoxic activity of quinoline-hydrazone hybrids.
Coa JC; Castrillón W; Cardona W; Carda M; Ospina V; Muñoz JA; Vélez ID; Robledo SM
Eur J Med Chem; 2015 Aug; 101():746-53. PubMed ID: 26218652
[TBL] [Abstract][Full Text] [Related]
4. Prospects of an alternative treatment against Trypanosoma cruzi based on abietic acid derivatives show promising results in Balb/c mouse model.
Olmo F; Guardia JJ; Marin C; Messouri I; Rosales MJ; Urbanová K; Chayboun I; Chahboun R; Alvarez-Manzaneda EJ; Sánchez-Moreno M
Eur J Med Chem; 2015 Jan; 89():683-90. PubMed ID: 25462275
[TBL] [Abstract][Full Text] [Related]
5. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
6. Rational design of nitrofuran derivatives: Synthesis and valuation as inhibitors of Trypanosoma cruzi trypanothione reductase.
Arias DG; Herrera FE; Garay AS; Rodrigues D; Forastieri PS; Luna LE; Bürgi MD; Prieto C; Iglesias AA; Cravero RM; Guerrero SA
Eur J Med Chem; 2017 Jan; 125():1088-1097. PubMed ID: 27810595
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo trypanocidal activity of some benzimidazole derivatives against two strains of Trypanosoma cruzi.
Díaz-Chiguer DL; Márquez-Navarro A; Nogueda-Torres B; de la Luz León-Ávila G; Pérez-Villanueva J; Hernández-Campos A; Castillo R; Ambrosio JR; Nieto-Meneses R; Yépez-Mulia L; Hernández-Luis F
Acta Trop; 2012 Apr; 122(1):108-12. PubMed ID: 22212465
[TBL] [Abstract][Full Text] [Related]
8. 5-Nitro-2-furfuriliden derivatives as potential anti-Trypanosoma cruzi agents: design, synthesis, bioactivity evaluation, cytotoxicity and exploratory data analysis.
Palace-Berl F; Jorge SD; Pasqualoto KF; Ferreira AK; Maria DA; Zorzi RR; de Sá Bortolozzo L; Lindoso JÂ; Tavares LC
Bioorg Med Chem; 2013 Sep; 21(17):5395-406. PubMed ID: 23816040
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a series of alpha-pyrone derivatives against Leishmania (L.) infantum and Trypanosoma cruzi.
Tempone AG; Ferreira DD; Lima ML; Costa Silva TA; Borborema SET; Reimão JQ; Galuppo MK; Guerra JM; Russell AJ; Wynne GM; Lai RYL; Cadelis MM; Copp BR
Eur J Med Chem; 2017 Oct; 139():947-960. PubMed ID: 28881289
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents.
Mendoza-Martínez C; Correa-Basurto J; Nieto-Meneses R; Márquez-Navarro A; Aguilar-Suárez R; Montero-Cortes MD; Nogueda-Torres B; Suárez-Contreras E; Galindo-Sevilla N; Rojas-Rojas Á; Rodriguez-Lezama A; Hernández-Luis F
Eur J Med Chem; 2015; 96():296-307. PubMed ID: 25899334
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity against Trypanosoma cruzi of substituted 1,4-naphthoquinones.
Olímpio da Silva A; da Silva Lopes R; Vieira de Lima R; Santos Suniga Tozatti C; Marques MR; de Albuquerque S; Beatriz A; Pires de Lima D
Eur J Med Chem; 2013 Feb; 60():51-6. PubMed ID: 23279867
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anti-Trypanosoma cruzi activity of derivatives from nor-lapachones and lapachones.
da Silva Júnior EN; de Souza MC; Fernandes MC; Menna-Barreto RF; Pinto Mdo C; de Assis Lopes F; de Simone CA; Andrade CK; Pinto AV; Ferreira VF; de Castro SL
Bioorg Med Chem; 2008 May; 16(9):5030-8. PubMed ID: 18378461
[TBL] [Abstract][Full Text] [Related]
13. Ligand-based design, synthesis, and experimental evaluation of novel benzofuroxan derivatives as anti-Trypanosoma cruzi agents.
Jorge SD; Palace-Berl F; Mesquita Pasqualoto KF; Ishii M; Ferreira AK; Berra CM; Bosch RV; Maria DA; Tavares LC
Eur J Med Chem; 2013 Jun; 64():200-14. PubMed ID: 23644203
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and trypanocidal activity of a library of 4-substituted 2-(1H-pyrrolo[3,2-c]pyridin-2-yl)propan-2-ols.
Balfour MN; Franco CH; Moraes CB; Freitas-Junior LH; Stefani HA
Eur J Med Chem; 2017 Mar; 128():202-212. PubMed ID: 28189084
[TBL] [Abstract][Full Text] [Related]
15. Novel nitroimidazole derivatives evaluated for their trypanocidal, cytotoxic, and genotoxic activities.
do Vale Chaves E Mello F; Castro Salomão Quaresma BM; Resende Pitombeira MC; Araújo de Brito M; Farias PP; Lisboa de Castro S; Salomão K; Silva de Carvalho A; Oliveira de Paula JI; de Brito Nascimento S; Peixoto Cupello M; Paes MC; Boechat N; Felzenszwalb I
Eur J Med Chem; 2020 Jan; 186():111887. PubMed ID: 31787363
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, physicochemical properties of allopurinol derivatives and their biological activity against Trypanosoma cruzi.
Raviolo MA; Solana ME; Novoa MM; Gualdesi MS; Alba-Soto CD; Briñón MC
Eur J Med Chem; 2013 Nov; 69():455-64. PubMed ID: 24090917
[TBL] [Abstract][Full Text] [Related]
17. Trypanosoma cruzi: effect and mode of action of nitroimidazole and nitrofuran derivatives.
Maya JD; Bollo S; Nuñez-Vergara LJ; Squella JA; Repetto Y; Morello A; Périé J; Chauvière G
Biochem Pharmacol; 2003 Mar; 65(6):999-1006. PubMed ID: 12623132
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease.
Filardi LS; Brener Z
Trans R Soc Trop Med Hyg; 1987; 81(5):755-9. PubMed ID: 3130683
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of Trypanosoma cruzi strains from Santander, Colombia, to hexadecylphosphocholine (miltefosine), nifurtimox and benznidazole.
Luna KP; Hernández IP; Rueda CM; Zorro MM; Croft SL; Escobar P
Biomedica; 2009 Sep; 29(3):448-55. PubMed ID: 20436996
[TBL] [Abstract][Full Text] [Related]
20. Structural design, synthesis and structure-activity relationships of thiazolidinones with enhanced anti-Trypanosoma cruzi activity.
Moreira DR; Leite AC; Cardoso MV; Srivastava RM; Hernandes MZ; Rabello MM; da Cruz LF; Ferreira RS; de Simone CA; Meira CS; Guimaraes ET; da Silva AC; dos Santos TA; Pereira VR; Soares MB
ChemMedChem; 2014 Jan; 9(1):177-88. PubMed ID: 24203393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
